Wedbush Securities’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Wedbush Securities’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,633	Closed	-$140K	–	997
2020 Q3	$140K	Buy	+1,633	New	+$190K	0.01%	799
2020 Q1	–	Sell	-667	Closed	-$28K	–	1026
2019 Q4	$28K	Buy	+667	New	+$14.6K	﹤0.01%	979
2015 Q2	–	Sell	-493	Closed	-$38K	–	782
2015 Q1	$38K	Hold	493	–	–	0.01%	704
2014 Q4	$49K	Hold	493	–	–	0.01%	680
2014 Q3	$48K	Hold	493	–	–	0.01%	663
2014 Q2	$73K	Buy	493 +20	+4%	+$3.1K	0.01%	624
2014 Q1	$81K	Hold	473	–	–	0.01%	588
2013 Q4	$72K	Hold	473	–	–	0.02%	549
2013 Q3	$104K	Hold	473	–	–	0.03%	508
2013 Q2	$53K	Buy	+473	New	+$54K	0.01%	514

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wedbush Securities's VBIV Position: Q4 2020 in Review

Wedbush Securities sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2020, closing a stake of 1,633 shares — an estimated $140K sold.

Wedbush Securities first reported a position in VBIV in Q2 2013 and held it in 10 quarters. The position peaked at $140K in Q3 2020. 122 funds tracked by Wall St. Rank hold VBIV as of Q4 2020.

Wedbush Securities reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2020 after selling out during the quarter.
Wedbush Securities sold 1,633 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2020, an estimated $140K.
Wedbush Securities first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2013 and held it in 10 quarters.
Wedbush Securities's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $140K in Q3 2020.
122 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.